Unidade Local de Saúde de Matosinhos
Matosinhos Municipality, Portugal
Location status: Recruiting
Location contact
Sílvia Correia, MD
CONTACT
NCT Number: NCT04903951
To evaluate the impact of early ventilation in stroke outcomes in patients with sleep apnea and first ever stroke, 1 month after stroke.
Interested in participating?
Request Info18 year–80 year
All sexes
Interventional
Phase 2
Matosinhos Municipality, Portugal
Location status: Recruiting
Sílvia Correia, MD
CONTACT
Single-center, randomized, open label, parallel arm, prospective study in patients with sleep apnea after first-ever stroke.
The study will consist of screening, baseline assessment, interventional period (consisting of a treatment period and follow-up visits), and a follow-up phone call.
Patients will be randomly assigned to ASV (active) or control groups, within 4 days after the PSG II and will start the respective intervention in the same day.
Patients assigned to the active group will receive ventilatory support with ASV (DreamStation BiPAP autoSV®) during diurnal and nocturnal sleep, from study randomization until clinically indicated. Patients assigned to control group will receive best medical treatment for stroke alone, including rehabilitation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients assigned to the active group will receive ventilatory support with ASV (DreamStation BiPAP autoSV®) during diurnal and nocturnal sleep, from study randomization until clinically indicated
Best medical treatment for stroke, including rehabilitation
Time frame: 1 month after stroke
Time frame: 4 and 6 months after stroke
Time frame: 1, 4 and 6 months after stroke
Time frame: Within 7 days after admission
Time frame: After 1, 4 and 6 months
% nights of device use; average hours per night of device use
Time frame: After 1, 4 and 6 months
Apnea-Hypopnea Index
Time frame: Through study completion, an average of 2 years
All AEs occurring within the period of observation for the clinical study must be fully evaluated, documented, reported (if applicable) and archived.
Time frame: 1, 4 and 6 months after stroke
Time frame: 12 months after stroke
Contact information is provided by the study sponsor or research team.
Philips Portuguesa S.A.
Industry
A Single-center, Randomized, Open Label, Parallel Arm, Prospective Study to Evaluate the Impact of Early Ventilation in Stroke Outcomes in Patients With Sleep Apnea After First Ever Stroke
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03255408
Apnea, Blood Pressure
Calgary, Alberta, Canada
View Trial DetailsNCT03812653
Apnea, Brain Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT04141891
Acute Coronary Syndrome, Aortic Stenosis, Subvalvular
La Jolla, California, United States
View Trial DetailsNCT02596087
Actinomycetales Infections, Anemia
Boston, Massachusetts, United States
View Trial Details